David Sheehan

President & Chief Executive Officer • Nucleus Biologics

Dave was previously at Volcano Corporation a publicly held life sciences company that was sold to Philips for $1.2 Billion. Dave held various roles including the COO, EVP Global Operations and General Manager Volcano Japan, and President of several business units.  Prior to Volcano, Dave was the President and CEO of Digirad a medical imaging company he took public in 2004.  Prior to that, Dave worked at Baxter and Haemonetics.  He has extensive experience in product creation, manufacturing scale up, managing growth and organization development. Dave earned a BSME with Distinction from WPI and an MBA from The Amos Tuck School at Dartmouth College.

Also Speaking

Roel Gordijn

Chief Commercial Officer • Polyplus

David Hermanson

Senior Manager, CGT Applications • Bio-Techne

Matthew Hewitt

Executive Director, Scientific Services, Cell & Gene Therapy (CGT) • Charles River

Also Speaking


Post-Event Report

Download the post-event report for Advanced Therapies Week 2023.

Investor List

Take a look at some of the investors who attended Advanced Therapies Week 2023.